Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 448 followers
Latest posts
Last updated 31 minutes ago
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 6, Status: Authorised
36 minutes ago
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation...
Summary of opinion: Pepaxti, 17/09/2026 Positive
3 days ago
Summary of opinion: Pepaxti, 17/09/2026 Positive
Report on the International Active Pharmaceutical Ingredient Inspection Programme 2017 – 2024
about 3 hours ago
Report on the International Active Pharmaceutical Ingredient Inspection Programme 2017 – 2024
Data Analysis and Real World Interrogation Network (DARWIN EU)
about 3 hours ago
Data Analysis and Real World Interrogation Network (DARWIN EU)
ICH M13B guideline on bioequivalence for immediaterelease solid oral dosage forms - additional strengths biowaiver - Step 5
about 6 hours ago
ICH M13B guideline on bioequivalence for immediaterelease solid oral dosage forms -...
ICH M13B guideline on bioequivalence for immediate-release solid oral dosage forms - additional strengths biowaiver: Questions and Answers - Step 5
about 6 hours ago
ICH M13B guideline on bioequivalence for immediate-release solid oral dosage forms -...
ICH guideline M13B on bioequivalence for immediate-release solid oral dosage forms - additional strengths biowaiver - Scientific guideline
about 6 hours ago
ICH guideline M13B on bioequivalence for immediate-release solid oral dosage forms -...
Programme of the 2026 annual meeting of the European network of paediatric research at EMA (EnprEMA)
3 days ago
Programme of the 2026 annual meeting of the European network of paediatric...
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 29, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 10, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation...
Summary of opinion: Enhertu, 17/09/2026 Positive
3 days ago
Summary of opinion: Enhertu, 17/09/2026 Positive
Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation: 14/02/2025, Revision: 8, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation...